|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/145 | (2013.01) |
| A61K 9/14 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/146 | (2013.01) | ||
| A61K 31/216 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 9/2077 | (2013.01) | ||
| A61K 31/14 | (2013.01) | ||
| A61K 31/19 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/08 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Patento numeris | 1519715 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03808363.0 |
| Europos patento paraiškos padavimo data | 2003-05-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-04-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-02-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2003/014542 |
| Data | 2003-05-23 |
| (87) | Numeris | WO 2004/041250 |
| Data | 2004-05-21 |
| (30) | Numeris | Data | Šalis |
| 383294 P | 2002-05-24 | US | |
| 370277 | 2003-02-21 | US |
| (72) |
RYDE, Tuula , US
GUSTOW, Evan, E. , US
RUDDY, Stephen, B. , US
JAIN, Rajeev
c/o Elan Drug Delivery , US
PATEL, Rakesh , US
WILKINS, Michael, John , IE
|
| (73) |
Alkermes Pharma Ireland Limited ,
Monksland, Athlone, County Westmeath,
IE
BGP Products Ireland Ltd. , 70, Sir John Rogerson's Quay, Dublin, IE |
| (54) | NANOPARTICULATE FIBRATE FORMULATIONS |
| NANOPARTICULATE FIBRATE FORMULATIONS |